$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About Advaxis, Inc.
Develops immunotherapies for cancer and infectious diseases
Sector
Health Technology
CEO
Kenneth A. Berlin
Industry
Biotechnology
Exchange
NAS
Website
Top Stories
Coming soon.